DDDR-26. IDENTIFICATION OF OLIG2 AS A PREDICTOR OF OSIMERTINIB’S EFFICACY AGAINST EGFRVIII+ GLIOBLASTOMA

Authors: Jackson Adams, Gita Kwatra, Zachary Bordeaux, Madan Kwatra

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.391

Source: Full article


Abstract

Abstract